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Abstract 
Methodology for the synthesis of the C7–C13 segment (19) and C14–C24 segment (41) of macrolactin A have 
been developed. Dicarbonyl(methyl 7-nitro-2E,4Z-heptadienoate)triphenylphosphineiron (19) is prepared 
by nucleophilic addition to a (1-methoxycarbonylpentadienyl)iron cation. The C23 stereocenter of 41 is 
established by introduction of a C20 stereocenter, chirality transfer from C20 to C23 followed by (diene)iron 
mediated selective ionic reduction of the C20 hydroxyl. The C15 stereocenter may be established by nitrile 
oxide–olefin cyclocondensation. 
Keywords 
Organoiron, macrolactin A, cyclocondensation 
 
Macrolactin A (1) is a 24-membered polyene macrolide isolated from a taxonomically undefined deep sea 
bacterium.1a This compound exhibits antiviral activity against Herpes Simplex I and II and against HIV. The 
macrocyclic lactone structure of 1, assigned on the basis of NMR spectroscopy,1a consists of three sets of 
conjugated dienes (C2–C5, C8–C11 and C16–19). The absolute stereochemistry of the four chiral centers (C7, 
C13, C15 and C23) were later assigned on the basis of chemical degradation and synthesis of the fragments.1b 
Since the culturing of this bacterium has been ‘unreliable’, further biological research must rely on total 
synthesis. Two elegant syntheses of macrolactin A2a,b and one of its 13,15-di-O-methyl derivative2c have been 
reported. Each of these syntheses utilizes Pd-catalyzed cross-coupling for installation of the C17–C18 and the 
C9–C10 bonds (Scheme 1). While the former coupling proceeds in excellent yields (82%), the latter coupling 
proceeds in only modest yield and was described in one case as ‘capricious’. In these syntheses, generation of 
the C7, C13, and C15 stereocenters was addressed in a variety of ways (chiral pool,2c asymmetric Sharpless 
epoxidation,2c asymmetric allylboration,2a or asymmetric aldol2b). Additional work concerning preparation of 
various segments of macrolactin A have been reported.3 
 
Scheme 1. Y/X=I or SnR3 or B(OH)2; FG/FG′=‘functional group’. 
 
An alternative organometallic route to macrolactin A relies on the application of stoichiometric acyclic 
(diene)iron complexes to organic synthesis.4., 5. One of the advantages of stoichiometric organometallic 
reagents is the ability to repeatedly utilize the same metal center to control a number of different bond forming 
reactions. Attachment of a carbonyl–iron adjunct to an acyclic diene has been shown to protect the diene 
against reduction, oxidation, and cycloaddition reactions.6 In addition, the steric bulk of the Fe(CO)3 group serves 
to effect diastereoselective bond formation at unsaturated centers adjacent to the coordinated diene. Finally, 
the electron-donor ability of the carbonyl–iron group allows for the generation of cationic centers adjacent to 
the coordinated diene (i.e. pentadienyl cations). Generation of the pentadienyl cation from an (E,E-dienol)iron 
complex in the presence of a weak nucleophile results in the formation of E,E-diene complexes, while reaction of 
isolable cisoid (pentadienyl)iron cations with stronger nucleophiles can lead to the formation of E,Z-diene 
complexes.7 
Our proposed synthetic strategy involves disconnection at the C13,C15 anti-diol group into two 
fragments 2 and 3 (Scheme 1). Recently, two groups independently reported the (diene)iron mediated, 
stereoselective preparation of this type of functionality via aldol condensations.5., 8. We focused our attention 
on utilizing nitrile oxide–olefin cycloaddition methodology9 for joining 
fragments 2 and 3 (FG/FG′=CH2NO2/CH CH2). Moreover, the 8E,10Z-diene segment 2 might be generated via 
nucleophilic addition to a cisoid (pentadienyl)iron cation. 
1. Results and Discussion 
1.1. Preparation of the C7–C13 segment of macrolactin A 
The (1-methoxycarbonylpentadienyl)Fe(CO)2L+ cations (3, L=CO)10 and (4, L=PPh3)11 were prepared by literature 
methods. We and others have shown that organocuprates react with acyclic (pentadienyl)iron(1+) cations with 
excellent regioselectivity.10., 12. The reaction of vinyl magnesium chloride with rac-3 in the presence of 
CuBr·Me2S gave (methyl 2E,4Z,7-octatrienoate)Fe(CO)3 (rac-5) (Scheme 2). The reaction of rac-5 with acetonitrile 
oxide (derived from nitroethane under Mukaiyama conditions13) gave an equimolar mixture of isoxazolines rac-
6a/b. The 2E,4Z-stereochemistries of triene 5 and isoxazolines 6a/b were assigned on the basis of their NMR 
spectral data. In particular, the signals for H2, H3, H4, and H5 appear at ca. δ (2.1 (d), 6.06 (dd), 5.35 (dd), and 
2.7–2.8 (m) ppm, respectively. Additionally the signals for C3 and C4 of 5 appear at δ 92.9 and 85.4 ppm, 
respectively. The diastereomeric isoxazolines 6a and 6b differ in the relative stereochemistry at C7 with respect 
to the diene–iron coordination. In contrast to the diastereoselective addition of nitrile oxides to (1,3,5-
triene)Fe(CO)3 complexes, the formation of 6a/b in a 1:1 ratio indicates that the steric bulk of the Fe(CO)3 group 
is too far distant from the pendent olefin and/or there is not a preferred reactive conformers about the C5–C6 
and C6–C7 bonds. 
 
Scheme 2. As the above approach was not diastereoselective, we sought to interchange the reactive 
functionality in fragments 2 and 3 by preparing a (7-nitro-2E,4Z-dienoate)iron complex. The reaction of 
cations rac-3 or rac-4 with the anion of nitromethane gave the pentenediyl complexes rac-7 or rac-8, 
respectively (Scheme 3). In a similar fashion, the reaction of cation rac-3 with the anion of ethyl nitroacetate 
gave predominantly (pentenediyl)Fe(CO)3 complex rac-9 (84%) accompanied by very minor amounts of 
(diene)Fe(CO)3 complex rac-10 (4%) as a separable mixture. Both 9 and 10 were isolated as mixtures of 
diastereomers at the (∗) carbon with respect to the ligand–iron coordination. 
 
Scheme 3. The structures of 7–9 were assigned by comparison of their NMR spectral data with that of other 
known (pentenediyl)iron complexes.11 In particular, the signals at ca. δ 7–9 ppm in their 13C NMR spectra are 
characteristic of a carbon which is σ-bound to iron while the signals at ca. δ 0.2–0.0 ppm in their 1H NMR spectra 
are characteristic of a proton on this type of carbon. The structural assignment for 10 was made by comparison 
of its NMR spectral data with that of known11 (E,Z-diene)Fe(CO)3 complexes. 
 
Nucleophilic attack of a variety of soft carbon nucleophiles, including nitromethane anion, on 
(cyclohexadienyl)Fe(CO)3+ cations occurs at the cyclohexadienyl terminus to afford substituted 
(cyclohexadiene)iron products.14 In contrast, the attack of ‘soft’ carbon nucleophiles, such as malonate anions, 
on acyclic (pentadienyl)iron(1+) cations bearing an electron withdrawing substituent proceeds at the C2 internal 
carbon to afford predominantly (pentenediyl)iron products.11., 15. This latter regioselectivity has been 
rationalized11 as being the result of charge control (i.e. greater δ+ charge at C2/C4) of cations 3 and 4. Since the 
pKa of nitromethane (17.2, DMSO as reference) is similar to that of dimethylmalonate (15.7), it might not be 
surprising that the regioselectivity for attack by nitromethane anion would be similar to that of malonate anion. 
The reaction of cation rac-4 with the anion of ethyl nitroacetate, followed by aqueous workup, gave the 
(pentenediyl)Fe(CO)2PPh3 complex rac-11 as an equimolar mixture of diastereomers (Scheme 4). In contrast to 
(pentenediyl)iron complex 9, which is constitutionally stable in solution, (pentenediyl)iron complex rac-
11 rearranges to (E,Z-diene)iron complex rac-12 upon standing in CDCl3 for 1–2 days! Thus, it may be inferred 
that attack of nitroacetate anion at C2 of 4 is the result of kinetic control. 
 
Scheme 4. Since several attempts to remove the C8 ethoxycarbonyl group from diene complex 12 were 
unsuccessful, the preparation of 2-(trimethylsilyl)ethyl nitroacetate (13) was undertaken (Scheme 5). Reaction of 
2-(trimethylsilyl)ethyl 2-bromoacetate (14)16 with NaNO2 (DMF/Δ) led to formation of the undesired 
nitrite 15 via O-alkylation. Reaction of 14 with NaI/acetone gave the iodoacetate 16, which without further 
purification was treated with AgNO2 in ether17 to give 13 via N-alkylation (55% based on consumed 16) along 
with minor amounts of the nitrite 15. The reaction of cation rac-4 with the anion of 13, followed by aqueous 
workup, gave the (pentenediyl)Fe(CO)2PPh3 complex rac-17 as an equimolar mixture of diastereomers (Scheme 
4). Pentenediyl complex rac-17 rearranges to rac-18 standing in CHCl3 solution for 6 days (50% yield from 4). 
 
 
Scheme 5. The interconversion of 11 to 12 occurs slower in C6D6 solution (as compared to CDCl3) such that ca. 
30% of 11 remained after 7 days. In addition, treatment of an ethyl acetate solution of 11 with saturated 
aqueous NH4Cl effected rapid rearrangement (<15 min) to 12. We propose that interconversion of the kinetically 
controlled product 11 into the thermodynamically more stable diene complex 12 (and likewise 17→18) occurs 
via protonation at the carbonyl oxygen followed by dissociation into the pentadienyl cation 4 and the ketene 
hemiacetal (Scheme 6). Recombination at C5 and deprotonation gives 12. Notably, we18 and others19 have 
previously reported that nucleophilic attack on acyclic (pentadienyl)iron cations is reversible in certain cases. 
 
 
Scheme 6. The structural assignments for 11, 12, 17 and 18 were made on the basis of their NMR spectral data. 
In particular, the signals at ca. δ 0.18 ppm in the 1H NMR spectra of both 11 and 17 are characteristic of a proton 
on a carbon which is σ-bound to iron. For both diene complexes 12 and 18 the two diastereomeric signals for H7 
appear as two sets of doublet of doublets at δ 4.69 and 4.57 ppm, indicating attachment of the nitroacetate 
group adjacent to a methylene carbon. Additionally, the signals for C3 and C4 appear at δ 90.4 and 86.9 ppm 
respectively, which is characteristic of a (2E,4Z-dienoate)iron complex (cf. 5). Notably, while the signals for H3 
of 12, 18 and 10 are relatively similar (δ 5.91, 5.92 and 6.08 ppm respectively) the signals for H4 
of 12 and 18 (δ 4.35 and 4.33, respectively) are shifted upfield compared to the corresponding signal 
of 10 (δ 5.31). This upfield shift may be attributed to the anisotropic effects of the triphenylphosphine ligand 
situated in the basal position of complexes 12 and 18 (cf. structure in Scheme 4). 
 
Removal of the 2-(trimethylsilyl)ethyl ester and decarboxylation of rac-18 to afford rac-19 could be achieved 
with TBAF (34–40%), however use of tris(dimethylamino)sulfur (trimethylsilyl)difluoride (TAS-F)20 gave 
considerably better yields (77%, Scheme 7). Reaction of triene–iron complex rac-2021a with the nitrile oxide 
generated in situ from rac-19 under Mukaiyama conditions gave the bimetallic tetraene isoxazoline 21. While 
four sets of racemic diastereomers are possible, examination of the NMR spectra of 21 indicated the presence 
of only two diastereomers. The ψ-exo relative stereochemistry at C-9 of rac-21 was assigned by comparison of 
the 13C NMR chemical shifts for C-9, C-10, and C-11 with those of the known21b ψ-exo and ψ-
endo dienylisoxazoline complexes 22 and 23. In particular, the diastereomeric signals for 21 (ca. δ 60, 44 and 
84 ppm) more closely match those of 22 (δ 59.4, 45.0 and 83.6 ppm) than those of 23 (δ 63.1, 48.0, and 
85.5 ppm). 
 
Scheme 7. In contrast to the non-diastereoselective nitrile oxide cyclocondensation to ‘skipped’ triene 
complex 5 (Scheme 2), addition of the nitrile oxide derived from 19 to the conjugated triene complex 20 occurs 
in a diastereoselective fashion. These results are consistent with approach of the nitrile oxide to a conjugated 
(triene)Fe(CO)3 complex, in its s-trans conformer, on the face opposite to the metal.21., 22. The 
Fe(CO)2PPh3 group present in 19 does not influence the stereochemical outcome of this condensation. 
 
1.2. Preparation of the C14–C24 segment of macrolactin A23 
The strategy for preparation of the C14–C24 segment, based on our model studies,4a relied on diastereoselective 
introduction of an asymmetric center adjacent to the (diene)Fe(CO)3 functionality at C20, relaying this 
asymmetry to the C23 center, and eventual removal of the initial stereocenter at C20. To this end, reaction of 
dienal complex rac-24 with the Grignard reagent generated from 2-(2-bromoethyl)-1,3-dioxane gave a mixture 
of rac-25 and rac-26 in disappointing yield (Scheme 8). Reaction of rac-24 with the alkyl lithium reagent derived 
from 2-(2-iodoethyl)-1,3-dioxane gave similar yields. The diastereoisomers are partially separable by column 
chromatography. The relative stereochemistries at C20 (macrolactin numbering) of 25 and 26 were tentatively 
assigned as ψ-exo and ψ-endo, respectively, on the basis of their relative chromatographic mobility (25 more 
polar than 26). It has been empirically found that ψ-exo diastereomeric alcohols are in general less mobile than 
their ψ-endo counterparts.24 Hydrolysis of rac-25 or rac-26 gave lactols rac-27 (46%) or rac-28 (14%), 
respectively; each lactol is a mixture of diastereomers at the hemiacetal carbon. 
 
Scheme 8. Due to the low yields of this two step route to the lactols, an alternative three step route was 
explored. The reaction of rac-24 with the allyl borane derived from (−)-(IPC)2BOMe,25 followed by oxidative 
workup gave (−)-29 (33–42% yield, 54–56% ee). Full details of this allylation, as well as chiral allylation of other 
(dienal)Fe(CO)3 complexes will be reported separately.26 The hydroboration–oxidation of 29 has been previously 
reported27 to afford only the 1,4-diol 30 (91%). In our hands, treatment of (−)-29 by the literature procedure 
gave a separable mixture of (−)-30 (44–57%) and 1,3-diol diastereomers 31 (20–37%) (Scheme 8). The 1H NMR 
spectral data for (−)-30 was identical with the literature data, while the identity 31 was established by 
independent synthesis (vide infra). Analysis of the 1H NMR spectra (C6D6) of the 20-(S)- and 20-(R)-MTPA ester-
23-TBDPS ethers 32 (derived from 30) indicated separation of the H18 signals (δ 5.16 and 5.24 ppm, 
respectively). The Mosher's esters 32 were determined to be ca. 55–57% de by integration of these signals. The 
absolute stereochemistry at C20 (S) was assigned based on the relative chemical shifts of the signals for H19 of 
each ((S)-32 δ 0.78 ppm vs. (R)-32 δ 0.66 ppm).28 Oxidation of 1,4-diol (−)-30 gave the lactol (−)-27 as a mixture 
of epimers. The spectral data for (−)-27 was identical with that of rac-27. 
 
Reductive hydrolysis of the known22 isoxazoline rac-33, followed by NaBH4 reduction of the resultant 
hydroxyketone gave rac-31 as a mixture of C22 epimers (Scheme 9). The ψ-exo relative stereochemistry of the 
diastereomeric mixture 31 was assigned by comparison of the 13C NMR chemical shifts of the diol methine 
carbons with those of the known21a isomers of (5,7-nonadien-2,4-diol)Fe(CO)3, anti-34 and syn-34, for which the 
structure of syn-34 was determined by X-ray diffraction analysis. In particular, the signals for the 
diastereomers 31 (δ 74.1, 71.3, 69.1 and 66.1 ppm) are similar to those of anti-34 (δ 72.4 and 65.8 ppm) 
and syn-34 (δ 75.5 and 69.1 ppm). The 1H NMR spectral data for rac-31 obtained in this fashion was identical to 
that for 31 obtained as a by-product of the hydroboration–oxidation of 29. The formation of significant amounts 
of product resulting from Markovnikov addition in the hydroboration of 4-hydroxy-1-alkenes has been 
previously noted.29 
 
Scheme 9. Tsuchihashi et al.30 have reported the methodology for the formation of syn-1,4-diols from lactols. 
They propose that this diastereoselectivity is the result of addition of a methyl–titanium nucleophile to a seven-
membered titanium chelate of the hydroxy-aldehyde. In the event, reaction of dienyl lactol (−)-27 with 
MeTi(iPrO)3 gave a single diastereomeric diol, (−)-35 (Scheme 10). After introduction of the C23 stereocenter by 
this methodology, removal of the superfluous C20 hydroxyl was required. Since dienyl dinitrobenzoate iron 
complexes undergo SN1 solvolysis with retention of configuration due to the generation of a transoid 
(pentadienyl)iron cation,31 it was anticipated that selective ionic reduction of the ψ-exo alcohol could be 
utilized.4., 5., 21. Reaction of (−)-35 with NaBH3CN in the presence of BF3·Et2O gave the alcohol (−)-36. The 
absolute stereochemistry of (−)-36 (i.e. 23R) was assigned on the basis of the relative chemical shifts of the C24 
methyl groups of the corresponding (R)- and (S)-MTPA esters 37 (δ 1.35 and 1.27 ppm, 
respectively).28 Integration of the MTPA methoxy signals (δ 3.54 and 3.57 ppm, respectively) indicated that the 
23-Mosher's esters 37 were ca. 50–54% de. Protection of (−)-36 as its TBS ether gave (−)-38. 
 
 
Scheme 10. The E,E-stereochemistries of dienoate complexes 25–28, 30–32, and 35–38 were assigned on the 
basis of their NMR spectral data. In particular the signals for H17 and H18 (macrolactin numbering) appear at 
ca. δ 5.8–5.7 and 5.5–5.2 ppm while the signals for C17 and C18 appear at ca. δ 87–85 and 85–83 ppm, 
respectively. These signals are distinctly different compared to the those of (E,Z-dienoate)Fe(CO)3 complexes 
(cf. 5). 
 
Reduction of ester (−)-38 (DIBAL/hexanes) followed by oxidation of the resultant primary alcohol (−)-
39 (nPrMgCl; 1,1′-(azodicarbonyl)dipiperidine) gave aldehyde (−)-40 (Scheme 11). The enantiomeric excess of 
(−)-40 was assayed by treatment with (1S,2S)-N,N′-dimethyl-1,2-diphenyl-ethylenediamine/molecular sieves32 to 
generate the diastereomeric imidazolidines. Integration of the diastereomeric methyl groups of the crude 
product (δ 2.54 and 2.19 ppm vs. δ 2.35 and 2.25 ppm) indicated the imidazolidines to be 55% de. Peterson 
olefination of (−)-40 gave the complexed triene (+)-41. Reaction of (+)-41 with 2-(2′-nitroethyl)-1,3-dioxane in 
the presence of phenylisocyanate and triethylamine led to the isolation of (−)-42. The relative stereochemistry 
of isoxazoline (−)-42 was assigned as ψ-exo by comparison of its 13C NMR spectral data for C15, C16, and C17 
(macrolactin numbering, δ 59.6, 45.0 and 83.5 ppm) to that of 22 and 23 (vide supra). This sequence of nine 
steps, (−)-29→(−)-42, allows for introduction of the C15 and C23 stereocenters, which are nine carbons 
separated, in a diastereoselective fashion. Reductive hydrolysis of (−)-42 (H2, Ra-Ni, MeOH/H2O, B(OH)3) for 5 h 
gave the β-hydroxy ketone 43, while reductive hydrolysis over 48 h resulted in loss of the Fe(CO)3 adjunct, and 
reduction of the conjugated diene and ketone functionalities to give 44. For 43 and 44, the stereochemistries at 
C15 and C23 are assigned as indicated based on the assignments for 42. 
 
Scheme 11. The E,E-diene stereochemistries of complexes 39, 41, 42, and 43 were assigned on the basis of their 
NMR spectral data. In particular the signals for H17 and H18 (macrolactin numbering) appeared at ca. δ 5.3–5.1 
and 5.05 ppm while the signals for C17 and C18 appear at ca. δ 85.5 and 83 ppm, respectively. These signals are 
characteristic of (E,Z-dienol)Fe(CO)3 complexes.33 
 
1.3. Summary 
Methodology for the construction of the C7–C13 and C14–C24 segments (19 and 41, respectively) of macrolactin 
A have been developed. For the former segment, the stereochemistry of the 8E,10Z-diene segment is 
established by a thermodynamically controlled addition of 2-(trimethylsilyl)ethyl nitroacetate to (1-methoxy-
carbonylpentadienyl)Fe(CO)2PPh3+ cation. For the latter segment, the C23 hydroxyl group is established by first 
generation of a C20 hydroxyl, followed by chirality relay of this asymmetry to the C23 center, and finally 
selective removal of the C20 hydroxyl. Furthermore, we have demonstrated that introduction of the C15 
stereocenter relative to the C16–C19 (diene)Fe(CO)3 group is possible by nitrile oxide–olefin cyclocondensation. 
Preparation of these segments in optically active form and eventual joining will be reported in due course. 
2. Experimental 
2.1. General data 
Spectrograde solvents were used without purification with the exception of tetrahydrofuran and ether which 
were distilled from sodium benzophenone ketyl, and dichloromethane which was distilled from P2O5. Anhydrous 
hexanes and DMSO were purchased as Aldrich sure-seal solvents and were used without further purification. 
Hexanes for chromatography was distilled through a 60 cm Vigreux column prior to use. Column 
chromatography was performed on silica gel 60 (60–200 mesh, Aldrich) and ‘flash’ chromatography was 
performed on silica gel 60 (230–400 mesh, Aldrich). 
Melting points were obtained on a Mel-Temp melting point apparatus and are uncorrected. Specific rotations 
were recorded on a Perkin–Elmer 341 optical polarimeter. Infrared spectra were recorded on a Mattson 4020 
FT-IR instrument. All 1H and 13C NMR spectra were recorded on a GE Omega GN-300 instrument at 300 and 
75 MHz, respectively. Diastereoisomeric carbon resonances are reported in brackets [ ]. Elemental analyses 
were obtained from Midwest Microlabs, Ltd., Indianapolis, IN, and high resolution mass spectra were obtained 
either from the Nebraska Center for Mass Spectrometry or the Washington University Resource for Biomedical 
and Bioorganic Mass Spectrometry. 
(Pentadienyl)iron cations 310 and 411 and (diene)iron complexes 24,10 (−)-29,26 and 3322 were prepared by 
literature procedures. 
Tricarbonyl(methyl-2E,4Z,7-octatrienoate)iron (5). A solution of vinyl magnesium chloride (0.84 mL, 1.0 M in 
THF, 0.84 mmol) was diluted with dry ether (2 mL) and THF (8 mL). The solution was cooled to −78°C, and solid 
CuBr·Me2S (57 mg, 0.28 mmol) was added. The mixture was stirred for 15 min, and then solid 3 (100 mg, 
0.244 mmol) was added. The reaction mixture was stirred for 1.5 h at −78°C and then warmed to 0°C and 
quenched with saturated aqueous NH4Cl and extracted with ether. The combined organic extracts were dried 
(MgSO4) and concentrated. The residue was purified by column chromatography (SiO2, hexanes–ethyl acetate 
(10:1)) to afford 5 as a yellow oil (30 mg, 42%): 1H NMR (CDCl3) δ 6.06 (dd, J=5.3, 8.5 Hz, 1H), 5.74 (dddd, J=6.1, 
7.2, 10.2, 16.8 Hz, 1H), 5.33 (dd, J=5.3, 7.6 Hz, 1H), 5.04–4.97 (m, 2H), 3.69 (s, 3H), 2.76 (dt, J=8.1, 7.8 Hz, 1H), 
2.27 (dt, J=15.3, 6.5 Hz, 1H), 2.17 (d, J=8.5 Hz, 1H), 1.90 (m, 1H); 13C NMR (CDCl3) δ 173.1, 138.0, 115.4, 92.9, 
85.4, 59.1, 46.0, 45.9, 33.2. This compound was used in the next reaction without further characterization. 
Diastereomeric isoxazolines (6). To a solution of 5 (60 mg, 0.20 mmol) and phenyl isocyanate (0.98 g, 8.3 mmol) 
in benzene (5 mL) was added a solution of nitroethane (0.31 g, 4.1 mmol) and triethylamine (3 drops) in benzene 
(2 mL). The mixture was stirred at room temperature for 48 h. The reaction mixture was passed through a short 
bed of SiO2 and the filter bed washed (hexane–ethyl acetate (1:1)). The filtrate was concentrated and purified by 
column chromatography (SiO2, hexane–ethyl acetate (10:1→10:3 gradient)) to give a mixture of 
diastereomers 6 as a yellow oil (40 mg, 57%): Rf 0.27 (hexanes–ethyl acetate (10:1)); 1H NMR (CDCl3) δ 6.06 
(dd, J=5.2, 8.5 Hz, 1H), 5.40 and 5.38 (2×dd, J=5.4, 7.5 Hz, 1H), 4.53 (ddt, J=4.4, 10.1, 7.2 Hz, 0.5H), 4.40 
(ddt, J=5.4, 10.3, 7.4 Hz, 0.5 H), 3.67 and 3.66 (2×s, 3H), 3.00 and 2.96 (2×ddd, J=1.0, 4.1, 17.1 Hz, total 1H), 2.79 
(dddd, J=1.2, 4.0, 7.9, 10.7 Hz, 0.5H), 2.68 (dddd, J=1.2, 4.3, 7.8, 9.9 Hz, 0.5H), 2.48 and 2.46 (2×ddd, J=1.0, 10.4, 
17.1 Hz, total 1H), 2.08 and 2.05 (2×d, J=8.8 Hz, total 1H), 1.97 (s, 3H), 1.29 (ddd, J=7.3, 10.1, 14.5 Hz, 1H), 1.16 
(ddd, J=5.4, 10.7, 14.1 Hz, 1H). 
(Tricarbonyl)(1-methoxycarbonyl-2-nitromethylene-3-pentene-1,5-diyl)iron (7). To absolute ethanol (20 mL) 
under N2, was added, in small portions, sodium metal (0.30 g, 13 mmol). Following the disappearance of sodium 
metal, nitromethane (1.60 g, 26 mmol) was added to the reaction mixture. The reaction mixture was 
concentrated to give a white solid. Freshly prepared sodium nitromethanate (0.40 g, 4.8 mmol) was dissolved in 
nitromethane (20 mL) and the cation 3 (1.00 g, 2.44 mmol) was added and the mixture was stirred for 45 min at 
5°C. Water (30 mL) was added to the mixture, the layers were separated, and the aqueous layer was extracted 
with ethyl acetate (3×50 mL). The combined organic layers were washed with brine (50 mL), dried (MgSO4) and 
concentrated. The residue was purified by column chromatography (SiO2, hexanes–ethyl acetate (4:1)) to 
afford 7 as a yellow oil (260 mg, 33%): IR (neat, cm−1) 3055, 2073, 2012, 1552, 1265; 1H NMR (CDCl3) δ 4.69 
(td, J=7.3, 11.7 Hz, 1H), 4.48 (t, J=6.4 Hz, 1H), 3.88 (m, 4H), 3.69 (s, 3H), 2.45 (dd, J=2.4, 12.5 Hz, 1H), 0.07 
(d, J=7.8 Hz, 1H); 13C NMR (CDCl3) δ 209.6, 209.4, 202.9, 179.2, 98.6, 80.2, 59.9, 54.8, 51.7, 37.4, 9.0; HRMS 
(EI) m/z 268.9996 (calcd for C9H11NO5Fe (M−2CO) m/z 268.9987). 
Dicarbonyl(1-methoxycarbonyl-2-nitromethylene-3-pentene-1,5-diyl)triphenylphosphineiron (8). To a solution 
of n-butyl lithium (0.2 mL, 1.6 M in hexanes) in THF (10 mL) at 0°C was added nitromethane (0.3 mL). To this 
solution was added a solution of 4 (250 mg, 0.406 mmol) in nitromethane (2 mL). The mixture was stirred at 0°C 
for 2 h and then poured into water (10 mL). The mixture was extracted with ethyl acetate (3×20 mL) and the 
combined organic extracts were washed with brine, followed by water, dried (MgSO4) and concentrated. The 
residue was purified by column chromatography (SiO2, hexanes–ethyl acetate (3:1)) to afford 8 as a yellow solid 
(180 mg, 96%): mp 152–153°C; 1H NMR (CDCl3) δ 7.50–7.20 (m, 15H), 4.20 (t, J=6.6 Hz, 1H), 4.04–3.88 (m, 2H), 
3.81–3.72 (m and s, 5H), 2.68 (m, 1H), 2.24 (ddd, J=2.7, 6.3, 11.7 Hz, 1H), 0.00 (dd, J=3.6, 8.4 Hz, 1H); 13C NMR 
(CDCl3) δ 217.2 (JPC=21.8 Hz), 216.8 (JPC=15.8 Hz), 180.7, 132.6 (JPC=9.6 Hz), 132.1, 130.4, 128.6 (JPC=9.7 Hz), 97.9, 
80.3, 57.7, 57.4, 51.3, 38.4, 7.1 (JPC=15.7 Hz); Anal. Calcd for C28H26NO6PFe2H2O: C, 56.49; H, 5.08. Found: C, 
56.38; H, 4.62. 
2.2. Reaction of 3 with ethyl nitroacetate anion 
To a solution of ethyl nitroacetate anion (0.28 mmol, freshly prepared from ethyl nitroacetate and n-butyl 
lithium) in THF (10 mL) cooled to 0°C was added solid cation 3 (0.10 g, 0.24 mmol). The reaction mixture was 
stirred for 30 min, warmed to room temperature and stirred overnight. Water (10 mL) was added, the layers 
were separated, and the aqueous layer was extracted several times with ethyl acetate and the combined organic 
layers were washed with brine, dried (MgSO4) and concentrated. The residue was purified by column 
chromatography (SiO2, hexanes–ethyl acetate (10:1)) to afford 10 as a yellow oil (38 mg, 4%), followed by 9 as a 
yellow oil (0.80 g, 84%). 
10: IR (neat, cm−1) 2073, 2011, 1552, 1265; 1H NMR (CDCl3) δ 6.08 (2× dd, each J=5.4, 8.8 Hz, 1H), 5.31 (dd, J=5.4, 
6.8 Hz, 1H), 5.09 (dd, J=3.4, 10.3 Hz, 1H), 4.90 (dd, J=6.1, 8.2 Hz, 1H), 4.27 (q, J=7.1 Hz, 2H), 3.70 (s, 3H), 2.49 (m, 
2H), 2.13 (dd, J=5.6, 8.3 Hz, 1H), 1.30 (t, J=7.1 Hz, 3H); 13C NMR (CDCl3) δ 172.5, 163.3, 93.8, 89.3 [89.1], 85.3 
[85.1], 63.4 [63.3], 51.8 [51.3], 50.5, 46.3 [46.2], 30.9 [30.5], 13.9. 
9: IR (neat, cm−1) 3059, 2075, 2011, 1749, 1699, 1562, 1267; 1H NMR (CDCl3) δ 4.68 (m, 1H), 4.46 (m, 2H), 4.30 
(qd, J=7.1, 7.1 Hz, 1H), 4.12 (m, 2H), 3.67 (s, 3H), 2.49 (d, J=12.5 Hz, 1H), 1.30 (t, J=7.1 Hz, 1H), 1.19 (t, J=7.1 Hz, 
3H), 0.22 (d, J=8.6 Hz, 1H); 13C NMR (CDCl3) δ 209.0, 209.4, 178.8, 162.2, 98.7 [98.3], 91.9, 63.1, 58.4, 55.1 [54.5], 
51.6, 39.9 [39.5], 13.9 [13.6], 9.0 [8.9]; HRMS (EI) m/z 267.0318 (calcd for C11H15O4Fe (M−3CO–
NO2) m/z 267.0324). 
2.3. Reaction of 4 with ethyl nitroacetate anion 
The reaction ethyl nitroacetate anion (0.232 mmol, freshly prepared from ethyl nitroacetate and n-butyl lithium) 
with 4 (100 mg, 0.155 mmol) was carried out in THF for 1 h, followed by workup with water. The mixture is 
extracted several times with Et2O, and the combined organic extracts were dried (MgSO4) and concentrated. 
The 1H NMR spectrum of the crude product indicated this to be (pentenediyl)iron complex 11: 1H NMR 
(CDCl3) δ 7.5–7.2 (m, 15H), 4.36–4.28 (m, 2H), 4.24–4.09 (m, 3H), 3.92 (m, 1H), 3.74 (s, 3H), 2.68 (m, 1H), 2.29 
(m, 1H), 1.35–1.15 (m, 3H), 0.18 (m, 1H). Workup of the above reaction mixture with saturated aqueous NH4Cl 
solution (instead of water) led to the exclusive formation of (diene)iron complex 12. Allowing a solution of 11 in 
CDCl3 to stand for 24–48 h, resulted in isomerization to 12. The isomerization of 11 to 12 proceeded 
considerably slower in C6D6 solution, such that ca. 30% of 11 remained after 7 days. 
2.4. Preparation of dicarbonyl(methyl ethyl 7-nitro-2E,4Z-
octadienedioate)triphenylphosphineiron (12) 
To a solution of ethyl nitroacetate anion (0.58 mmol, freshly prepared from ethyl nitroacetate and n-butyl 
lithium) in THF (10 mL) at 0°C was added a solution of cation 4 (250 mg, 0.387 mmol) in THF (10 mL). The 
mixture was stirred at 0°C for 3 h. Saturated aqueous NH4Cl (20 mL) was added and the mixture was extracted 
with ethyl acetate (2×25 mL). The combined organic extracts were washed with water, followed by brine, dried 
(MgSO4) and concentrated. The residue was purified by column chromatography (SiO2, hexanes–ethyl acetate 
(10:1→3:1 gradient)) to afford 12 as a yellow solid (170 mg, 70%): mp 54–59°C; IR (CHCl3) 1994, 1934, 
1703 cm−1; 1H NMR (CDCl3) δ 7.50–7.35 (m, 15H), 5.95–5.87 (m, 1H), 4.69 (dd, J=4.5, 9.6 Hz, 0.5H), 4.57 
(dd, J=4.5, 9.9 Hz, 0.5H), 4.37–4.28 (m, 1.5H), 4.20–4.10 (m, 2.5H), 3.68 (s, 3H), 2.65 (br m) and 2.30 (br m) total 
1H, 1.90 (br s, 1H), 1.40 (m, 1H), 1.22 (t, J=7.2 Hz, 3H); 13C NMR (CDCl3) δ 174.5, 163.6, 133.7 (br), 133.0 
(JPC=9.7 Hz), 130.3, 128.4 (JPC=9.7 Hz), 90.4 (br), 90.1, 89.4, 86.9 (br), 62.8, 51.3, 40.0 (br), 30.6 (br), 13.7; Anal. 
Calcd for C31H30NO8PFe: C, 58.97; H, 4.79. Found: C, 58.91; H, 4.92. 
2-(Trimethylsilyl)ethyl nitroacetate (13). To a solution of sodium iodide (4.37 g, 29.1 mmol) in acetone (30 mL) 
was added dropwise 2-(trimethylsilyl)ethyl 2-bromoacetate16 (3.48 g, 14.6 mmol). The reaction mixture was 
stirred for 16 h, and then washed with water, followed by brine. The mixture was extracted with ethyl acetate 
and the combined organic extracts were dried (MgSO4) and concentrated to give crude 2-(trimethyl-silyl)ethyl 2-
iodoacetate as a brown liquid (4.17 g). 1H NMR (CDCl3) δ 4.23 (m, 2H), 3.68 (s, 2H), 1.02 (m, 2H), 0.05 (s, 9H). The 
crude iodoacetate was added to a suspension of AgNO3 (3.36 g, 21.8 mmol) in dry ether (85 mL) at 0°C. The 
reaction mixture was stirred for 32 h with protection from light. The reaction mixture was filtered, and the filter 
bed washed with CH2Cl2. The combined filtrates were concentrated and the residue was purified by column 
chromatography (SiO2, hexanes–ethyl acetate (5:1)) to give recovered iodoacetate (2.57 g), followed by 
nitroacetate 13 as a pale oil (631 mg), and finally nitrite 15. 
13: 1H NMR (CDCl3) δ 5.14 (s, 2H), 4.35 (m, 2H), 1.06 (m, 2H), 0.05 (s, 9H); 13C NMR (CDCl3) δ 161.9, 76.4, 65.8, 
17.2, −1.7; Anal. Calcd for C7H15NO4Si: C, 40.96; H, 7.36. Found: C, 41.75; H, 7.41. 
15: 1H NMR (CDCl3) δ 4.27 (m, 2H), 4.11 (s, 2H), 1.02 (m, 2H), 0.02 (s, 9H). 
2.5. Reaction of 4 with 2-(trimethylsilyl)ethyl nitroacetate anion 
To a solution of 2-(trimethylsilyl)ethyl nitroacetate anion (0.58 mmol, freshly prepared from 2-
(trimethylsilyl)ethyl nitroacetate and n-butyl lithium at 0°C) in THF (40 mL) was added solid cation 4 (1.00 g, 
1.55 mmol) in one portion. The mixture was stirred at room temperature for 2 h. The reaction mixture was 
diluted with water and extracted several times with Et2O, and the combined organic extracts were dried 
(MgSO4) and concentrated. The 1H NMR spectrum of the crude product indicated it to be (pentenediyl)iron 
complex 17 (1.1 g): 1H NMR (CDCl3) δ 7.46–7.26 (m, 15H), 4.38 (m, 2H), 4.18 (m, 3H), 3.92 (br m, 1H), 3.74 (s, 
3H), 2.66 (m, 1H), 2.28 (m, 1H), 1.06 (m, 2H), 0.18 (m, 1H), 0.05 and 0.00 (2×s, 9H). The product was divided into 
three roughly equal samples and each was dissolved in CHCl3 (1 L each). The flasks were protected from the light 
and allowed to stand for 6 days. The solvent was evaporated and the combined residues were purified by 
column chromatography (‘flash’ SiO2, hexanes–ethyl acetate (15:1) to afford 18 as a yellow oil (544 mg, 50%). 1H 
NMR (CDCl3) δ 7.48–7.36 (m, 15H), 5.95 (dd, J=4.7, 7.9 Hz, 0.5H), 5.90 (dd, J=4.7, 7.7 Hz, 0.5H), 4.69 (dd, J=4.9, 
10.5 Hz, 0.5H), 4.57 (dd, J=4.4, 10.6 Hz, 0.5H), 4.39–4.26 (m, 1H), 4.22–4.16 (m, 2H), 3.69 (s, 3H), 2.65 (br m) and 
2.32 (br m) total 1H, 1.92 (br s, 1H), 1.39 (br m, 2H), 0.90 (dd, J=8.2, 10.8 Hz, 2H), 0.20 and 0.14 (2×s, 9H). This 
product was used in the next reaction without further characterization. 
Dicarbonyl(methyl 7-nitro-2E,4Z-heptadienoate)(triphenylphosphine)iron [rac-(19)]. To a solution 
of 18 (540 mg, 0.768 mmol) in DMF (5 mL) was added tris(dimethylamino)sulfur (trimethylsilyl)difluoride (TAS-F) 
(215 mg, 0.783 mmol) and the reaction mixture was stirred for 18 h. The mixture was diluted with water and 
extracted with ethyl acetate. The combined extracts were dried (MgSO4) and concentrated. The residue was 
purified by column chromatography (SiO2, hexanes–ethyl acetate (10:1)) to afford 19 as a yellow oil (330 mg, 
77%): 1H NMR (CDCl3) δ 7.49–7.36 (m, 15H), 5.93 (ddd, J=1.2, 5.1, 7.9 Hz, 1H), 4.37 (br m, 1H), 4.03 (m, 2H), 3.68 
(s, 3H), 2.20 (m, 2H), 1.88 (br d, J=7.7 Hz, 1H), 1.42 (m, 1H); 13C NMR (CDCl3) δ 212.1, 211.8, 175.4, 134.4 
(JPC=41 Hz), 133.8 (JPC=11 Hz), 131.1, 129.2 (JPC=10 Hz), 91.0, 87.6 (br), 77.8, 55.1, 52.1, 40.9 (br), 28.1; HRMS 
(FAB) m/z 566.0998 (calcd for C28H26NO6PFeLi (M+Li+) m/z 566.0998). 
Isoxazoline rac-(21). To a solution of nitrodienoate iron complex rac-19 (150 mg, 0.270 mmol) and triene iron 
complex rac-20 (64 mg, 0.270 mmol) in benzene (5 mL) was added phenyl isocyanate (45 μL, 0.405 mmol) and 
triethylamine (38 μL, 0.270 mmol). The mixture was stirred for 24 h. Water (10 mL) was added and mixture 
extracted with ether. The organic layer was washed with water, brine, dried (MgSO4) and concentrated. The 
white crystalline byproduct formed was washed with hexanes to extract the product. Purification by (SiO2, 
hexane–ethyl acetate (10:1)) gave a mixture of diastereomers 21 as a yellow oil (88 mg, 42%): 1H NMR 
(CDCl3) δ 7.51–7.31 (m, 15H), 5.93 (m, 1H), 5.15 (dd, J=4.0, 8.3 Hz, 1H), 5.08 (m, 1H), 4.37 (br m, 1H), 4.1–4.0 (m, 
1H), 3.68 (s, 3H), 2.62 (m, 1H), 2.4–2.2 (m, 3H), 1.96–1.81 (m, 2H), 1.43 and 1.42 (2×d, J=6.0 Hz, 3H), 0.93–0.78 
(m, 2H); 13C NMR (CDCl3) δ 212.1, 175.4, 159.8, 134.6 (JPC=41 Hz), 133.8 (JPC=10 Hz), 131.0, 129.2 (JPC=9 Hz), 91.3, 
88.2, 84.2 [84.1], 83.6, 60.0, 59.9, 59.6, 55.5 (br), 52.0, 44.1, 41.3 (br), 28.2, 19.8; HRMS (FAB) m/z 782.0879 
(calcd for C38H34NO8PFe2Li (M+Li+) m/z 782.0880). 
2.6. Grignard addition to rac-(24) 
To a suspension of flame dried magnesium turnings (1.68 g, 0.07 mol) in THF (50 mL) was added, dropwise, a 
solution of 2-(2-bromoethyl)-1,3-dioxane (10.34 g, 0.053 mol) in THF (50 mL). After completion of the addition, 
the mixture was heated at reflux for 90 min, and then cooled in an ice-water bath. A solution of rac-24 (10 g, 
0.035 mol) in THF (100 mL) was added dropwise. The reaction mixture was warmed to room temperature and 
stirred for 16 h. Ice and saturated aqueous NH4Cl (30 mL) were added to the reaction mixture and the layers 
were separated. The aqueous layer was extracted with ether (2×40 mL) and the combined organic layers were 
washed successively with saturated aqueous NH4Cl (2×40 mL), water (2×40 mL), and brine (40 mL), dried 
(MgSO4) and concentrated. The residue was purified by column chromatography (SiO2, hexanes–ethyl acetate 
(4:1)) to afford 26 as a yellow solid (0.52 g, 4%), followed by a mixture of 26 and 25 (1.95 g, 14%) and 
finally 25 as a yellow solid (1.71 g, 12%). 
rac-25: IR (CHCl3, cm−1) 3449, 2058, 1989, 1711; 1H NMR (CDCl3) δ 5.83 (ddd, J=0.7, 5.0, 8.1 Hz, 1H), 5.51 
(dd, J=4.9, 8.7 Hz, 1H), 4.60 (t, J=4.2 Hz, 1H), 4.11 (m, 2H), 3.77 (dt, J=2.4, 11.8 Hz, 2H), 3.65 (s, 3H), 3.59 (m, 1H), 
3.26 (d, J=4.6 Hz, OH), 2.04 (m, 1H), 1.9–1.6 (m, 5H), 1.30 (m, 1H), 1.02 (d, J=8.4 Hz, 1H); 13C NMR 
(CDCl3) δ 172.5, 101.6, 85.4, 83.9, 72.4, 67.0, 66.9, 51.6, 45.9, 32.7, 30.8, 25.5, 14.1; HRMS (EI) m/z 340.0592 
(calcd for C14H20O6Fe (M−2CO)+ 340.0612). 
rac-26: IR (CHCl3, cm−1) 3462, 2058, 1987, 1711; 1H NMR (CDCl3) δ 5.80 (dd, J=5.1, 8.2 Hz, 1H), 5.43 (dd, J=4.9, 
8.8 Hz, 1H), 4.60 (t, J=3.9 Hz, 1H), 4.09 (m, 2H), 3.76 (m, 3H), 3.65 (s, 3H), 3.20 (d, J=3.2 Hz, OH), 2.04 (m, 1H), 
1.84–1.63 (m, 5H), 1.34 (m, 1H), 0.92 (d, J=8.1 Hz, 1H); 13C NMR (CDCl3) δ 172.7, 101.6, 84.0, 82.8, 72.4, 66.9, 
51.6, 45.4, 34.3, 31.8, 25.4, 15.2; HRMS (EI) m/z 340.0606 (calcd for C14H20O6Fe (M−2CO)+ 340.0612). 
2.7. Preparation of lactol rac-27 via hydrolysis of 25 
To a solution of rac-25 (0.18 g, 0.45 mmol) in degassed acetone (30 mL) was added 0.05 M H2SO4 (4 mL). The 
mixture was heated at reflux for 6 h. The mixture was cooled, solid NaHCO3 was added and the mixture 
concentrated. The residue was extracted with ether and the combined organic extracts were washed with H2O 
followed by brine, dried (MgSO4) and concentrated. The residue was purified by column chromatography (SiO2, 
hexanes–ethyl acetate (4:1)) to give rac-27 as a yellow solid (0.07 g, 46%): IR (KBr, cm−1) 3374, 2066, 2014, 1973, 
1715; 1H NMR (300 MHz, CDCl3) δ 5.85 (dd, J=5.1, 8.1 Hz, 1H), 5.58 (m, 0.5H), 5.48 (t, J=4.1 Hz, 0.5H), 5.43 (m, 
1H), 4.03 (q, J=7.8 Hz, 0.5H), 3.84 (q, J=8.3 Hz, 0.5H), 3.67 (s, 3H), 2.56 (br s, OH), 2.3–1.7 (m, 4H), 1.33 
(t, J=8.3 Hz, 0.5H), 1.17 (d, J=8.1 Hz, 1H), 1.10 (d, J=8.7 Hz, 0.5H); 13C NMR (CDCl3) δ(172.4 [172.3], 99.4 [99.2], 
86.1 [86.0], 85.0 [84.8], 82.8 [80.0], 65.5 [63.0], 51.7, 46.6 [46.5], 34.5 [33.6], 32.1 [31.3]; HRMS 
(EI) m/z 338.0079 (calcd for C13H14O7Fe (M+) 338.0093); Anal. Calcd for C13H14O7Fe: C, 46.18; H, 4.17. Found: C, 
46.42; H, 4.17. 
2.8. Preparation of lactol rac-28 via hydrolysis of 26 
The hydrolysis of rac-26 was carried out in the same fashion as the hydrolysis of rac-25 (14%): IR (KBr, cm−1) 
3374, 2066, 2014, 1973, 1715; 1H NMR (300 MHz, CDCl3) δ 5.80 (dd, J=5.1, 8.2 Hz, 1H), 5.53 and 5.49 
(2×t, J=2.7 Hz, 1H), 5.38 and 5.30 (2×dd, J=5.1, 8.7 Hz, 1H), 4.21 (q, J=6.8 Hz, 0.5H), 3.80 (q, J=8.1 Hz, 0.5H), 3.66 
(s, 3H), 2.59 (m, OH), 2.4–1.8 (m, 4H), 1.46 (t, J=8.7 Hz, 0.5H), 1.29 (dd, J=8.6 Hz, 0.5H), 1.03 and 0.96 
(2×d, J=8.3 Hz, 1H); 13C NMR (CDCl3) δ(172.6, 98.5 [98.4], 84.8 [84.1], 83.6 [83.3], 82.7 [78.8], 68.6 [66.6], 51.7, 
46.0 [45.6], 34.6 [33.3], 32.5 [31.8]; HRMS (EI) m/z 282.0198 (calcd for C11H14O5Fe (M−2CO)+ 282.0185); Anal. 
Calcd for C13H14O7Fe: C, 46.18; H, 4.17. Found: C, 46.50; H, 4.20. 
2.9. Hydroboration–oxidation of 2926 
To a solution of (−)-29 (2.43 g, 7.55 mmol) in dry THF (25 mL), cooled to 0°C was added a solution of BH3·THF 
complex (9.1 mL, 1.0 M, 9.1 mmol) in THF. The mixture was stirred at 0°C for 1 h and then treated with a 
solution of 30% H2O2 (8.5 mL) and 1.0 M aqueous KOH. After stirring for 1 min, the mixture was poured into a 
separatory funnel containing brine (50 mL) and ether (50 mL). The layers were separated and the organic layer 
was washed with water, followed by brine, dried (MgSO4) and concentrated. The resultant orange oil was 
purified by column chromatography (SiO2, hexanes–ethyl acetate (1:1) to give 31 (0.95 g, 37%). The spectral data 
for 31 was identical with that obtained of a sample prepared by an independent route (vide infra). Further 
elution with ethyl acetate gave (−)-30 as a yellow solid (1.30 g, 51%). 
(−)-30: mp 72–75°C [lit.26 mp 86–87°C (rac-30)]; [α]D=−109° (c 0.60, MeOH); 1H NMR (CDCl3) δ 5.84 (dd, J=5.1, 
8.1 Hz, 1H), 5.50 (dd, J=5.1, 8.6 Hz, 1H), 3.72 (m, 2H), 3.66 (s, 3H), 3.60 (m, 1H), 2.60 (br s, OH), 1.95–1.62 (m, 
5H), 1.33 (t, J=7.8 Hz, 1H), 1.05 (d, J=8.1 Hz, 1H); 13C NMR (CDCl3) δ(172.6, 85.6, 84.0, 72.9, 66.7, 62.6, 51.7, 46.0, 
36.1, 28.4; HRMS (FAB) m/z 341.0321 (calcd for C13H17O7Fe (M+H) 341.0324). The 1H NMR spectrum of (−)-30 in 
C6D6 was identical with the literature26 data for rac-30. 
Tricarbonyl(methyl 9-tert-butyldiphenylsilyloxy-6-hydroxy-2,4-nonadienoate)iron. To a solution of (−)-
30 (100 mg, 0.294 mmol) in CH2Cl2 (3 mL) was added t-butyldiphenylsilylchloride (81 mg, 0.294 mmol) and 
imidazole (20 mg). The reaction mixture was stirred for 3 h at which time TLC monitoring (SiO2, hexanes–ethyl 
acetate (1:1)) indicated completion. The mixture was concentrated and the residue was purified by column 
chromatography (SiO2, hexanes–ethyl acetate (4:1)) to give a yellow oil (130 mg, 76%): 1H NMR (CDCl3) δ 7.69–
7.66 (m, 4H), 7.46–7.35 (m, 6H), 5.84 (ddd, J=1.0, 5.1, 8.1 Hz, 1H), 5.53 (dd, J=5.2, 8.4 Hz, 1H), 3.75–3.59 (m, 3H), 
3.67 (s, 3H), 3.18 (br s, OH), 1.88 (m, 1H), 1.74–1.60 (m, 3H), 1.34 (dd, J=7.2, 7.8 Hz, 1H), 1.05 (s and m, 10H); 13C 
NMR (CDCl3) δ(172.6, 135.5, 133.1, 129.8, 127.7, 85.3, 83.8, 72.8, 67.2, 64.3, 51.7, 45.9, 36.6, 28.6, 26.7, 19.1. 
This compound was used in the next reaction without further characterization. 
(S)-MTPA ester of tricarbonyl(methyl 9-tert-butyldiphenylsilyloxy-6-hydroxy-2,4-nonadienoate)iron [(S)-
(32)]. To a solution of the above secondary alcohol (55 mg, 0.095 mmol) in CH2Cl2 (3 mL) was added (S)-α-
methoxy(trifluoromethyl)phenyl acetic acid (67 mg, 0.285 mmol), DMAP (7 mg) and DCC (60 mg, 0.285 mmol). 
The reaction mixture was stirred for 2 h, and then quenched by the addition of H2O (5 drops). The mixture was 
extracted several times with ether, and the combined extracts washed with 3% aqueous HCl, followed by water 
and finally brine, dried (MgSO4) and concentrated. The residue was purified by column chromatography (SiO2, 
hexanes–ethyl acetate (4:1)) to give (S)-32 as a yellow oil (50 mg, 89%). Analysis by 1H NMR spectroscopy (C6D6) 
indicated that the product was 57% de. The 1H NMR spectral data for the major diastereomer is as follows: 
(C6D6) δ 7.78–7.73 (m, 3H), 7.64 (br d, J=6.9 Hz, 2H), 7.28–7.21 (m, 6H), 7.12–7.06 (m, 4H), 5.38 (dd, J=5.4, 
8.4 Hz, 1H), 5.16 (dd, J=5.1, 8.4 Hz, 1H), 4.90 (dt, J=3.0, 9.6 Hz, 1H), 3.69–3.46 (m, 2H), 3.43 (s, 3H), 3.30 (s, 3H), 
1.92 (m, 1H), 1.7–1.4 (m, 3H), 1.17 (s, 9H), 0.92 (d, J=8.4 Hz, 1H), 0.78 (t, J=8.7 Hz, 1H). 
(R)-MTPA ester of tricarbonyl(methyl 9-tert-butyldiphenylsilyloxy-6-hydroxy-2,4-nonadienoate)iron [(R)-
(32)]. The preparation of the (R)-MTPA ester 32 was carried out in the same fashion as the preparation of the 
(S)-MPTA ester 32 (97%). Integration of analysis by 1H NMR spectroscopy (C6D6) indicated that the product was 
55% de. The 1H NMR spectral data for the major diastereomer is as follows: 1H NMR (C6D6) δ 7.78–7.73 (m, 3H), 
7.64 (br d, J=6.9 Hz, 2H), 7.28–7.21 (m, 6H), 7.12–7.06 (m, 4H), 5.42 (ddd, J=0.9, 5.1, 8.4 Hz, 1H), 5.24 
(ddd, J=0.9, 5.1, 8.4 Hz, 1H), 4.85 (dt, J=3.3, 9.3 Hz, 1H), 3.62–3.48 (m, 2H), 3.41 (s, 3H), 3.28 (s, 3H), 1.92 (m, 1H), 
1.7–1.4 (m, 3H), 1.17 (s, 9H), 0.84 (d, J=8.4 Hz, 1H), 0.66 (t, J=8.7 Hz, 1H). 
Tricarbonyl(methyl 6,8-dihydroxy-2,4-nonadienoate)iron [rac-(31)]. To a solution of rac-3322 (130 mg; 
0.388 mmol) in MeOH–H2O (15:1, 5 mL) in a three-necked flask was added Raney-nickel (ca. 0.5 mL slurry in 
H2O) and B(OH)3 (60 mg). The flask was fitted with a balloon, the flask purged twice with H2, and the balloon 
inflated with H2 gas. The reaction mixture was stirred for 5 h at rt and then the mixture was filtered through 
filter-aid and extracted with ether. The combined ether extracts were concentrated and the residue was purified 
by column chromatography (SiO2, hexanes–ethyl acetate (17:3→3:1 gradient)) to give (methyl 6-hydroxy-8-oxo-
2,4-nonadienoate)Fe(CO)3 as a yellow oil (40 mg, 30%): 13C NMR (CDCl3) δ 208.9, 172.3, 85.4, 84.2, 69.0, 64.4, 
51.6, 50.7, 46.3, 30.5. This product was used without further characterization. To a solution of the 
hydroxyketone (40 mg, 0.12 mmol) in EtOH (5 mL), at 0°C, was added solid NaBH4 (3 mg). The solution was 
stirred for 10 min, at which time TLC monitoring (hexanes–ethyl acetate (2:3)) indicated disappearance of the 
ketone. The reaction mixture was diluted with water and extracted with CH2Cl2. The combined organic extracts 
were washed with brine, dried (MgSO4) and concentrated. The residue was purified by column chromatography 
(SiO2, hexanes–ethyl acetate (1:1) to give rac-31 (15 g, 37%). 1H NMR (CDCl3) δ 5.84 (m, 1H), 5.50 (dd, J=5.1, 
8.6 Hz, 1H), 4.25 (m, 0.3H), 4.05 (m, 0.7H), 3.84 (m, 0.3H), 3.75 (m, 0.7H), 3.66 (s, 3H), 2.60 (br s, OH), 1.8–1.6 
(m, 3H), 1.27 and 1.25 (m and 2×d, J=7.2 Hz, 4H), 1.07 (d, J=8.5 Hz, 0.3 H), 1.05 (d, J=8.4 Hz, 0.7H); 13C NMR 
(CDCl3) δ 172.5, 85.1 [85.5], 84.1 [84.2], 74.1 [71.3], 69.1 [66.1], 65.8 [66.8], 51.7, 46.2 [46.1], 44.7, 24.5 [23.5]. 
2.10. Preparation of lactol (−)-27 via oxidation of (−)-30 
To a solution of (−)-30 (130 mg, 0.382 mmol), DMSO (0.08 mL) and triethylamine (0.16 mL) in CH2Cl2 (8 mL) at 
0°C was added SO3pyridine (182 mg, 1.15 mmol). The reaction mixture as stirred at 0°C for 2 h, and for an 
additional 3.5 h at room temperature. The reaction mixture was quenched with cold water (3 mL) and extracted 
with ethyl acetate. The combined organic layers were washed successively with saturated aqueous NH4Cl, 
saturated aqueous NaHCO3, and finally brine, dried (MgSO4) and concentrated. The residue was purified by 
column chromatography (SiO2, hexanes–ethyl acetate (4:1→13:7 gradient)) to give (−)-27 as a yellow oil (70 mg, 
54%): [α]D=−263° (c 0.60, MeOH). The 1H NMR spectrum of (−)-27 was identical to that of rac-27. 
Tricarbonyl(methyl 6,9-dihydroxy-2,4-decadienoate)iron (−)-35. A solution of chlorotriisopropoxy–titanium in 
hexanes (6.9 mL, 1.0 M, 6.9 mmol) was diluted with dry Et2O (20 mL) and cooled in a CH3CN/liquid N2 bath. To 
this solution was added dropwise via syringe a solution of MeLi (4.96 mL, 1.4 M, 4.6 mmol) in Et2O. The solution 
was warmed to 0°C and stirred for 1 h. The resulting suspension was allowed to settle and the liquid layer was 
transferred, by cannula under N2 pressure, to a filtration apparatus containing a celite filter bed. The solution 
was filtered, and the solvent was evaporated under high vacuum. The residue was taken up in dry CH2Cl2 (20 mL) 
and cooled to −78°C. A solution of (−)-27 (470 mg, 1.39 mmol) in dry CH2Cl2 (6 mL) was slowly added via syringe. 
The mixture was warmed to room temperature and stirred for 18 h. The mixture was cooled to 0°C and 
quenched with CH3OH until gas evolution ceased. The mixture was poured into ice water (100 mL) and 
additional CH2Cl2 was added. The layers were separated and the aqueous layer was extracted with CH2Cl2. The 
combined organic phases were washed with H2O, followed by brine, dried (MgSO4) and concentrated. The 
residue was purified by column chromatography (SiO2, hexanes–ethyl acetate (3:2) followed by ethyl acetate) to 
give (−)-35 as a pale yellow solid (250 mg, 51%): mp 108–111°C; [α]D=−110° (c 0.16, MeOH); 1H NMR 
(CDCl3) δ 5.83 (dd, J=5.1, 8.1 Hz, 1H), 5.50 (dd, J=5.1, 8.7 Hz, 1H), 3.88 (m, 1H), 3.66 (s, 3H), 3.57 (m, 1H), 1.92–
1.82 (m, 1H), 1.76–1.50 (m, 5H), 1.33 (t, J=7.8 Hz, 1H), 1.23 (d, J=6.3 Hz, 3H), 1.04 (d, J=8.1 Hz, 1H); 13C NMR 
(CDCl3) δ 172.6, 85.5, 83.9, 73.4, 68.2, 67.2, 51.7, 46.0, 35.5, 35.3, 23.7; HRMS (FAB) m/z 355.0468 (calcd for 
C14H19O7Fe (M+H)+ 355.0480); Anal. Calcd for C14H18O7Fe: C, 48.04; H, 5.25. Found: C, 47.48; H, 5.12. 
Tricarbonyl(methyl 9-hydroxy-2,4-decadienoate)iron [(−)-36]. To a solution of (−)-35 (250 mg, 0.706 mmol) in 
dry THF (25 mL) cooled to −78°C was added NaBH3CN (0.45 g, 7.0 mmol). The mixture was stirred at this 
temperature for 1 h, and then Et2O·BF3 (7 mL) was added dropwise. The mixture was allowed to warm 
overnight. Water (10 mL) was added dropwise, and the mixture was partially concentrated, extracted with 
ether, and the combined organic phases washed with saturated aqueous NaHCO3, water, and finally brine, dried 
(MgSO4) and concentrated. The residue was purified by chromatography (SiO2, hexane–ethyl acetate (4:1)) to 
give (−)-36 as a yellow oil, (170 mg, 71%): [α]D=−120° (c 0.16, MeOH); 1H NMR (CDCl3) δ 5.78 (dd, J=5.1, 8.1 Hz, 
1H), 5.22 (dd, J=5.1, 8.7 Hz, 1H), 3.80 (m, 1H), 3.65 (s, 3H), 1.76–1.30 (m, 8H), 1.20 (d, J=6.3 Hz, 3H), 0.97 
(d, J=8.4 Hz, 1H); 13C NMR (CDCl3) δ 172.6, 87.2, 83.0, 67.7, 65.3, 51.6, 45.6, 38.6, 34.1, 28.2, 23.6. The spectral 
data for (−)-35 was identical with that provided by Dr Grée. 
(S)-MTPA ester of tricarbonyl(methyl 9-hydroxy-2,4-decadienoate)iron [(S)-(37)]. The preparation of the (S)-
MTPA ester of (−)-36 was carried out in the same fashion as the preparation of the (S)-MPTA ester 32 (98%). 
Analysis by 1H NMR spectroscopy (CDCl3) indicated that the product was ca. 50% de. The 1H NMR spectral data 
for the major diastereomer is as follows: 1H NMR (CDCl3) δ 7.59–7.51 (m, 2H), 7.44–7.38 (m, 3H), 5.77 (dd, J=5.1, 
8.1 Hz, 1H), 5.15 (m) and 5.11 (dd, J=5.1, 8.7 Hz) total 2H, 3.66 (s, 3H), 3.57 (s, 3H), 1.8–1.4 (m, 5H), 1.35 
(d, J=6.0 Hz, 3H), 1.3–1.13 (m, 2H), 0.93 (d, J=8.7 Hz, 1H). 
(R)-MTPA ester of tricarbonyl(methyl 9-hydroxy-2,4-decadienoate)iron [(R)-(37)]. The preparation of the (R)-
MTPA ester of (−)-36 was carried out in the same fashion as the preparation of the (S)-MPTA ester of 32 (91%). 
Analysis by 1H NMR spectroscopy (CDCl3) indicated that the product was ca. 54% de. The 1H NMR spectral data 
for the major diastereomer is as follows: 1H NMR (CDCl3) δ 7.59–7.51 (m, 2H), 7.44–7.38 (m, 3H), 5.78 (dd, J=4.8, 
7.5 Hz, 1H), 5.15 (m, 2H), 3.66 (s, 3H), 3.54 (s, 3H), 1.8–1.4 (m, 5H), 1.3–1.13 (m) and 1.27 (d, J=6.0 Hz) total 5H, 
0.96 (d, J=8.1 Hz, 1H). 
Tricarbonyl[methyl 9-(t-butyldimethylsilyl)oxy-2,4-decadienoate]iron [(−)-38]. To a solution of (−)-36 (270 mg, 
0.799 mmol) in CH2Cl2 (8 mL) was added imidazole (110 mg, 1.60 mmol), t-butyldimethylsilyl chloride (170 mg, 
1.12 mmol) and a few crystals of DMAP. The reaction mixture was stirred for 18 h, at which time TLC (hexane–
ethyl acetate (7:3)) indicated the disappearance of the alcohol. The solvent was evaporated and the residue was 
purified by column chromatography (SiO2, hexanes–ethyl acetate (9:1)) to give (−)-38 as a yellow oil (357 mg, 
99%): [α]D=−92° (c 0.08, MeOH); 1H NMR (CDCl3) δ 5.78 (ddd, J=1.0, 5.1, 8.0 Hz, 1H), 5.21 (dd, J=5.1, 9.0 Hz, 1H), 
3.78 (m, 1H), 3.65 (s, 3H), 1.8–1.2 (m, 7H), 1.11 (d, J=6.0 Hz, 3H), 0.97 (dd, J=0.9, 8.1 Hz, 1H), 0.88 (s, 9H), 0.05 (s, 
6H); 13C NMR (CDCl3) δ 172.6, 87.2, 82.9, 68.3, 65.7, 51.5, 45.6, 39.2, 34.4, 28.2, 25.9, 23.7, 18.1, −4.4, −4.8. The 
spectral data for (−)-35 was identical with that provided by Dr Grée. 
Tricarbonyl[9-(t-butyldimethylsilyl)oxy-2,4-decadien-1-ol]iron [(−)-39]. A solution of (−)-38 (170 mg, 
0.376 mmol) in anhydrous hexanes (7 mL) was cooled to −30°C and a solution of DIBAL (0.76 mL, 1.0 M, 
0.76 mmol) in hexanes was added. The reaction was stirred at −30°C for 90 min, and then methanol (1 mL) was 
cautiously added, followed by saturated aqueous NH4Cl. The mixture was extracted with ethyl acetate and the 
combined extracts washed with brine, dried (MgSO4) and concentrated. The residue was purified by column 
chromatography (SiO2, hexanes–ethyl acetate (4:1)) to give (−)-39 as a yellow oil (130 mg, 81%): [α]D=−23° 
(c 0.22, MeOH); 1H NMR (CDCl3) δ 5.16 (dd, J=4.8, 8.4 Hz, 1H), 5.07 (dd, J=5.0, 9.0 Hz, 1H), 3.82–3.58 (m, 3H), 
1.70–1.15 (m, 9H), 1.11 (d, J=6.0 Hz, 3H), 0.88 (s, 9H), 0.05 (s, 6H); 13C NMR (CDCl3) δ 212.0, 85.3, 82.5, 68.3, 
65.1, 64.8, 60.3, 39.2, 34.4, 28.3, 25.9, 23.8, 18.1, −4.4, −4.7. The spectral data for (−)-35 was identical with that 
provided by Dr Grée. 
Tricarbonyl[methyl 9-(t-butyldimethylsilyl)oxy-2,4-decadienal]iron [(−)-40]. To a solution of (−)-39 (150 mg, 
0.354 mmol) in THF (10 mL), was added a solution of n-propyl magnesium bromide (0.2 mL, 2.0 M, 0.4 mmol) in 
ether. The solution was stirred at rt for 15 min, and then solid (azodicarbonyl)dipiperidine (103 mg, 0.405 mmol) 
was added in one portion. The reaction mixture was stirred for 1 h. The reaction mixture was quenched with 
brine and extracted with ether. The combined ether extracts were washed with brine, dried (MgSO4) and 
concentrated. The residue was purified by column chromatography (SiO2, hexanes–ethyl acetate (9:1)) to give 
(−)-40 as a yellow oil (120 mg, 80%): [α]D=−49° (c 0.16, MeOH); 1H NMR (CDCl3) δ 9.26 (d, J=4.5 Hz, 1H), 5.78 
(dd, J=4.8, 8.4 Hz, 1H), 5.28 (dd, J=5.0, 8.4 Hz, 1H), 3.79 (m, 1H), 1.74–1.36 (m, 7H), 1.26 (ddd, J=0.9, 4.5, 8.1 Hz, 
1H), 1.12 (d, J=6.0 Hz, 3H), 0.88 (s, 9H), 0.05 (s, 6H); 13C NMR (CDCl3) δ 196.0, 88.5, 81.3, 68.2, 66.9, 54.7, 39.2, 
34.4, 28.2, 25.9, 23.8, 18.1, −4.4, −4.8. The spectral data for (−)-35 was identical with that provided by Dr Grée. 
Tricarbonyl[10-(t-butyldimethylsilyl)oxy-1,3,5-undecatriene]iron [(+)-41]. To magnesium turnings (50 mg, 
2.1 mmol) in dry ether (3 mL) was slowly added a solution of chloromethyltrimethylsilane (121 mg, 0.99 mmol) 
in ether (3 mL). The mixture was stirred at room temperature for 1 h, heated at reflux for 30 min, and then 
cooled to −78°C. A solution of (−)-40 (230 mg, 0.545 mmol) in ether (3 mL) was added and the solution was 
stirred at −78°C for 1 h. The solvent was evaporated under reduced pressure and the residue was taken up in 
CH2Cl2 (10 mL). To this solution was added 2% aqueous H2SO4 (3 drops) and silica gel (60–200 mesh, 1.0 g) and 
the mixture was stirred overnight at room temperature. The mixture was extracted with ether, the combined 
extracts were washed with saturated aqueous NaHCO3, followed by water, and then brine, dried (MgSO4) and 
concentrated. The residue was purified by column chromatography (SiO2, hexanes–ethyl acetate (50:1→9:1 
gradient)) to give (+)-41 as a yellow oil (120 mg, 52%) followed by recovered (−)-40 (30 mg). [α]D=+18° (c 0.16, 
MeOH); IR (CDCl3, cm−1) 2043, 1975; 1H NMR (CDCl3) δ 5.75 (dt, J=16.5, 10.2 Hz, 1H), 5.22–5.16 (m, 2H), 5.02 
(dd, J=5.4, 9.0 Hz, 1H), 4.94 (dd, J=1.2, 10.2 Hz, 1H), 3.78 (m, 1H), 1.73 (t, J=9.3 Hz, 1H), 1.63–1.20 (m, 7H), 1.12 
(s, J=6.3 Hz, 3H), 0.89 (s, 9H), 0.05 (s, 6H); 13C NMR (CDCl3) δ 212.1, 139.0, 114.5, 84.3, 81.8, 68.4, 64.0, 61.2, 
39.3, 34.4, 28.4, 25.9, 23.8, 18.1, −4.4, −4.7. 
Isoxazoline [(−)-42]. To a solution of (+)-41 (120 mg, 0.284 mmol) and 2-(2-nitroethyl)-1,3-dioxane (90 mg, 
0.56 mmol) in benzene (5 mL) was added phenyl isocyanate (65 mg, 0.55 mmol), and triethylamine (55 mg, 
0.55 mmol). The mixture was stirred for 24 h after which monitoring by TLC (hexane–ethyl acetate (17:3)) 
indicated some starting material 41 remaining. Additional 2-(2-nitroethyl)-1,3-dioxane (90 mg, 0.56 mmol), 
phenyl isocyanate (65 mg, 0.55 mmol), and triethylamine (55 mg, 0.55 mmol) were added and the reaction 
mixture was stirred for an additional 12 h. Water (10 mL) was added and mixture extracted with ether. The 
organic layer was washed with water, brine, dried (MgSO4) and concentrated. The white crystalline byproduct 
formed was washed with hexanes to extract the product. Purification by chromatography (flash SiO2, hexane–
ethyl acetate (17:3)) gave (−)-42 (96 mg, 60%) as a yellow oil: [α]D=−36° (c 0.16, MeOH); IR (CDCl3, cm−1) 2047, 
1979; 1H NMR (CDCl3) δ 5.23 (dd, J=4.9, 8.2 Hz, 1H), 5.08 (dd, J=5.0, 8.8 Hz, 1H), 4.74 (t, J=4.8 Hz, 1H), 4.26 
(q, J=9.3 Hz, 1H), 4.11 (m, 3H), 3.76 (m, 4H), 3.18 (dd, J=10.3, 17.6 Hz, 1H), 2.86 (dd, J=8.6, 17.6 Hz, 1H), 2.64 
(t, J=3.9 Hz, 2H), 2.07 (m, 1H), 1.73–1.20 (m, 6H), 1.10 (d, J=6.0 Hz, 3H), 1.02 (t, J=8.9 Hz, 1H), 0.88 (s, 9H), 0.04 
(s, 6H); 13C NMR (CDCl3) δ 155.0, 99.4, 86.3, 83.5, 83.0, 68.2, 66.8, 65.8, 59.6, 45.0, 39.1, 34.3, 33.6, 28.2, 25.8, 
25.4, 23.7, 18.0, −4.5, −4.8; HRMS (FAB) m/z 564.2072 (calcd for C26H42O7NSiFe (M+H)+ 564.2079). 
β-Hydroxyketone (43). To a solution of (−)-42 (32 mg; 0.056 mmol) in MeOH–H2O (15:1, 10 mL) in a three-
necked flask was added Raney-nickel (ca. 1 mL slurry in H2O) and B(OH)3 (20 mg). The flask was fitted with a 
balloon, the flask purged twice with H2, and the balloon inflated with H2 gas. The reaction mixture was stirred for 
5 h at rt and then the mixture was filtered through filter-aid and extracted with ether. The combined ether 
extracts were concentrated and the residue was purified by column chromatography (SiO2, hexanes–ethyl 
acetate (7:3)) to give 43 as a yellow oil (7 mg, 22%): 1H NMR (CDCl3) δ 5.28 (dd, J=5.0, 8.3 Hz, 1H), 5.07 (dd, J=5.0, 
8.7 Hz, 1H), 4.93 (t, J=5.2 Hz, 1H), 4.08 (m, 3H), 3.76 (m, 4H), 3.41 (d, J=3.4 Hz, OH), 2.97–2.65 (m, 3H), 2.05 (m, 
1H), 1.65–1.20 (m, 8H), 1.12 (d, J=6.2 Hz, 3H), 0.88 (s, 9H), 0.04 (s, 6H); 13C NMR (CDCl3) δ 208.0, 98.6, 85.5, 82.7, 
70.1, 68.4, 66.9, 65.2, 62.3, 51.3, 48.9, 39.2, 34.3, 28.2, 25.8, 25.3, 23.7, 18.0, −4.5, −4.8; LRMS (FAB) m/z 451.3 
(calcd for C20H27O8Fe (M−TBS)+ 451.1). 
2-[12-(t-Butyldimethylsilyl)oxy-2,4-dihydroxytridecyl)-1,3-dioxane (44). To a solution of (−)-42 (50 mg; 
0.089 mmol) in MeOH–H2O (15:1, 10 mL) in a three-necked flask was added Raney-nickel (ca. 1 mL slurry in H2O) 
and B(OH)3 (30 mg). The flask was fitted with a balloon, the flask purged twice with H2, and the balloon inflated 
with H2 gas. The reaction mixture was stirred for 48 h at rt and then the mixture was filtered through filter-aid 
and extracted with ether. The combined ether extracts were concentrated and the residue was purified by 
column chromatography (SiO2, hexanes–ethyl acetate (7:3)) to give 44 as a pale oil (14 mg, 36%): 1H NMR 
(CDCl3) δ 4.79 (dd, J=4.8, 5.6 Hz, 1H), 4.28 (m, 1H), 4.13 (m, 3H), 3.95–3.70 (m, 5H), 2.10 (m, 1H), 1.87 (m, 1H), 
1.60 (m, 2H), 1.45–1.20 (m, 16H), 1.10 (d, J=6.3 Hz, 3H), 0.88 (s, 9H), 0.03 (s, 6H); 13C NMR (CDCl3) δ 101.6, 69.0, 
68.6, 66.9, 66.8, 66.0, 42.5, 41.5, 41.4, 39.7, 37.5, 29.6, 25.9, 25.7, 25.6, 23.8, 18.1, −4.4, −4.7; HRMS 
(FAB) m/z 455.3176 (calcd for C23H48O5SiNa (M+Na)+ 455.3169). 
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